Showing 181-200 of 723 for: Cochrane Systematic Reviews > Musculoskeletal 
- Corticosteroids for treating nerve damage in leprosy
Cochrane Systematic Reviews, 5-Jul-2011
Leprosy causes nerve damage which can result in nerve function impairment and disability. Corticosteroids are commonly used for treating nerve damage, although the long-term effect is uncertain. This is an update of a review first published in 2007 and pr
- Corticosteroids for treating optic neuritis
Cochrane Systematic Reviews, 14-Aug-2015
Optic neuritis is an inflammatory disease of the optic nerve. It usually presents with an abrupt loss of vision and recovery of vision is almost never complete. It occurs more commonly in women than in men. Closely linked in pathogenesis, optic neuritis m
- Corticosteroids for treating sepsis
Cochrane Systematic Reviews, 18-Jan-2016
Sepsis occurs when an infection is complicated by organ failures as defined by a sequential organ failure assessment (SOFA) score of two or higher. Sepsis may be complicated by impaired corticosteroid metabolism. Giving corticosteroids may benefit patient
- Corticosteroids for tuberculous pleurisy
Cochrane Systematic Reviews, 25-Oct-2008
Corticosteroids used in addition to antituberculous therapy have been reported to benefit people with tuberculous pleurisy. However, research findings are inconsistent, raising doubt as to whether such treatment is worthwhile. Concern also exists regardin
- Corticosteroids for viral myocarditis
Cochrane Systematic Reviews, 18-Oct-2013
Myocarditis is defined as inflammation of the myocardium accompanied by myocellular necrosis. Experimental evidence suggests that autoimmune mechanisms follow viral infection, resulting in inflammation and necrosis in the myocardium. However, the use of c
- Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms
Cochrane Systematic Reviews, 18-Jun-2015
This is an updated version of the original Cochrane review published in Issue 1, 2007.
- Corticosteroids or ACTH for acute exacerbations in multiple sclerosis
Cochrane Systematic Reviews, 12-Nov-2013
Corticosteroids are commonly used to improve the rate of recovery from acute exacerbation in multiple sclerosis (MS) patients. However, it is unclear just how effective these agents are and which is the best treatment schedule (type of drug, dose, frequen
- Creatine for treating muscle disorders
Cochrane Systematic Reviews, 9-May-2013
Progressive muscle weakness is a main symptom of most hereditary and acquired muscle diseases. Creatine improves muscle performance in healthy individuals. This is an update of our 2007 Cochrane review that evaluated creatine treatment in muscle disorders
- Cyclical progestogens for heavy menstrual bleeding
Cochrane Systematic Reviews, 6-Nov-2008
Excessively heavy menstrual bleeding (HMB) or menorrhagia is an important cause of ill health in women. Eighty per cent of women treated for HMB have no anatomical pathology, which makes medical therapy, with the avoidance of possibly unnecessary surgery,
- Cyclobenzaprine for the treatment of myofascial pain in adults
Cochrane Systematic Reviews, 18-Apr-2012
Myofascial pain (MP) is a painful condition characterized by pain transmitted from trigger points (TP) within myofascial structures (in the muscles), local or distant from the pain. TPs can produce a characteristic pattern of irradiated pain or autonomic
- Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis
Cochrane Systematic Reviews, 9-Nov-2008
Raynaud's is a vasodilatory phenomenon characterised by digital pallor, cyanosis and pain of the extremities. Primary Raynaud's phenomenon has no underlying disease associated with it, while secondary Raynaud's phenomenon is associated with conective tiss
- Cyclo-oxygenase (COX) inhibitors for treating preterm labour
Cochrane Systematic Reviews, 21-May-2015
Preterm birth is a major cause of perinatal mortality and morbidity. Cyclo-oxygenase (COX) inhibitors inhibit uterine contractions, are easily administered and appear to have few maternal side effects. However, adverse effects have been reported in the fe
- Cyclophosphamide for treating rheumatoid arthritis
Cochrane Systematic Reviews, 24-May-2010
The use of immunosuppressive drugs for the treatment of RA has been advocated for decades. Cyclophosphamide is an antineoplastic agent widely used in the treatment of cancer patients. It is an alkylating drug, with a marked cytotoxic effect on mononuclear
- Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus
Cochrane Systematic Reviews, 28-Jan-2013
Neuropsychiatric involvement in systemic lupus erythematosus (SLE) is complex and it is an important cause of morbidity and mortality. Management of nervous system manifestations of SLE remains unsatisfactory. This is an update of a Cochrane review first
- Cyclosporin as an oral corticosteroid sparing agent in stable asthma
Cochrane Systematic Reviews, 19-Sep-2010
Patients with chronic severe asthma are often dependent on the long term prescription of oral corticosteroids. The use of steroids is associated with serious side effects. Physicians treating such patients continue to search for alternative therapies that
- Cyclosporine for treating rheumatoid arthritis
Cochrane Systematic Reviews, 24-May-2010
Rheumatoid arthritis (RA) is an autoimmune disease characterized by an activation of T lymphocyte and an increase in interleukine turnover. In RA, cyclosporine is known to be efficient as a Disease Modifying Anti-Rheumatic Agent (DMARD), especially when o
- Danazol for heavy menstrual bleeding
Cochrane Systematic Reviews, 10-Nov-2008
Heavy menstrual bleeding (HMB) is an important cause of ill health in pre menopausal women. Medical therapy, with the avoidance of possibly unnecessary surgery is an attractive treatment option, but there is considerable variation in practice and uncertai
- Dapsone as an oral corticosteroid sparing agent for asthma
Cochrane Systematic Reviews, 10-Mar-2011
Oral corticosteroids are used as a treatment for asthma, however they are often associated with serious side effects. Dapsone is a sulfone with anti-inflammatory properties, therefore it may have a beneficial effect in the treatment of asthma and act as a
- Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis
Cochrane Systematic Reviews, 28-Oct-2014
Deep transverse friction massage, one of several physical therapy interventions suggested for the management of tendinitis pain, was first demonstrated in the 1930s by Dr James Cyriax, a renowned orthopedic surgeon in England. Its goal is to prevent abnor
- Dehydroepiandrosterone for systemic lupus erythematosus
Cochrane Systematic Reviews, 15-Sep-2008
Systemic lupus erythematosus (SLE) is a chronic inflammatory, multisystem autoimmune condition. Dehydroepiandrosterone (DHEA) is a naturally occurring inactive steroid which may possess disease activity modifying properties as well as the ability to reduc
